Brief: Kyongbo Pharmaceutical receives patent
21/09/2016 07:06
Sept 21 (Reuters) - Kyongbo Pharmaceutical Co Ltd
214390.KS :
* Says it receives patent on Sept. 21, for method for the
preparation of high purity Rosuvastatin Calcium salt
Source text in Korean: https://goo.gl/XdlkNt
Further company Coverage: 214390.KS
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +861062674724;
Reuters Messaging: lima.jin.reuters.com@reuters.net))
Recent news on Kyongbo Pharmaceutical
See all newsBrief: Kyongbo Pharmaceutical Q1 Operating Profit 713 Million Won, Up 489.3% From Year Earlier
Brief: Kyongbo Pharmaceutical Q3 Operating Profit 474 Million Won, Down 85% From Year Earlier
Brief: Kyongbo Pharmaceutical Q2 Operating Profit 2.4 Billion Won, Up 90% From Year Earlier
Brief: Kyongbo Pharmaceutical To Invest 85.5 Billion Won In Building Additional Factory
Brief: Kyongbo Pharmaceutical Q2 Operating Profit 1.3 Billion Won, Down 14.8% From Year Earlier